News

Daiichi Sankyo and the Heart Rhythm Society announced results from a global survey, which polled cardiologists from around the world and revealed that a majority (58 percent) agree there is no...

Medtronic, Reveal Linq ICM, atrial fibrillation, AF, study, remote monitoring

Medtronic announced the results of a new "real-world" study of patients who have had a cryptogenic stroke, in which the Reveal Linq Insertable Cardiac Monitor (ICM) detected atrial fibrillation (...

Medi-Lynx Cardiac Monitoring LLC and Medicalgorithmics have announced their participation in a research project investigating the impact of lifestyle modification on ablation outcome in atrial...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Ablation system, atrial fibrillation, Medtronic Arctic Front Advance Cryoballoon

Medtronic announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial.

AliveCor, Heart Monitor, atrial fibrillation, AF, ECG, Cleveland Clinic, study

Cleveland Clinic and AliveCor, Inc. announced the online publication of study results from Cleveland Clinic’s iTransmit Study, "Evaluating the Efficacy and Feasibility...

Ablation Catheters, Atrial Fibrillation, EP Lab, FlexAbility Ablation Catheter

St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility Ablation Catheter, a new ablation technology used by electrophysiologists for the treatment of...

Savaysa, Daiichi Sankyo, edoxaban, FDA, approval, NVAF, thromboembolism

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of...

CardioFocus, HeartLight Endoscopic Ablation System, Japan Lifeline, distribution

CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an exclusive, multi-year distribution...

Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment...

AliveCor Heart Monitor, third generation, ECG, atrial fibrillation, AF

AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have the ability to identify and manage heart conditions with a U.S. Food and Drug Administration...

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and...

EP Lab, Atrial Fibrilation, RhythmView 3-D Mapping System, MIP Award

Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New Product (MIP) Award at the 2014 CONNECT MIP Awards.

cardiovascular surgery, atrial fibrillation, Minneapolis Heart Institute Found.

Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started following a new set of guidelines for certain patients recovering from cardiovascular surgery...

Medi‐Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project, investigating the impact of lifestyle modification on ablation outcome in atrial fibrillation (...

AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab

Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with atrial fibrillation.

AFIB, BMI, Loyola University Medical Center, Epicardial Adipose Tissue

Obesity is commonly measured as a person’s body mass index (BMI), but a Loyola University Medical Center study has found that the layer of fat around the outside of the heart is more closely...

atrial fibrillation, FDA, Dual Epicardial and Endocardial Procedure, DEEP

Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S Food and Drug Administration Approval (FDA). 

New physician experience for the Convergent Procedure in the treatment of persistent atrial fibrillation (AF) was presented during a podium talk at the Northeast Cardiothoracic Surgical Society...

Topera, Abbott, FIRMap, rotors, rotor mapping

Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device company focused on developing electrophysiology technologies to improve the diagnosis and...